Published in Stem Cell Res Ther on August 19, 2013
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? World J Stem Cells (2016) 0.86
Regulation of fibroblast lipid storage and myofibroblast phenotypes during alveolar septation in mice. Am J Physiol Lung Cell Mol Physiol (2014) 0.83
Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine. Theranostics (2017) 0.77
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med (1994) 14.46
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
The human serum metabolome. PLoS One (2011) 5.55
The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med (1998) 2.94
CC chemokines in allergic inflammation. Immunol Today (1994) 2.85
Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell (2009) 2.48
In situ isolation of mRNA from individual plant cells: creation of cell-specific cDNA libraries. Proc Natl Acad Sci U S A (1995) 2.43
Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc Res (2010) 2.06
Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med (2010) 2.01
TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity (1997) 1.98
Current strategies for articular cartilage repair. Eur Cell Mater (2005) 1.91
Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum (2003) 1.90
Clinical applications of mesenchymal stem cells. J Hematol Oncol (2012) 1.86
Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem (2007) 1.86
The healing and regeneration of articular cartilage. J Bone Joint Surg Am (1998) 1.82
Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med (2007) 1.70
Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res (2007) 1.65
Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. J Orthop Res (2006) 1.50
Articular cartilage: structure, injuries and review of management. Br Med Bull (2008) 1.46
Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica (2007) 1.44
Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol (2011) 1.42
Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int (2012) 1.41
A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One (2010) 1.39
Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology. Stem Cell Res Ther (2011) 1.28
Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res (2010) 1.27
CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis. PLoS One (2011) 1.25
Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther (2013) 1.24
Chondrocyte moves: clever strategies? Osteoarthritis Cartilage (2007) 1.13
A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy (2005) 1.12
Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int (2012) 1.09
Chemokine regulation of normal and pathologic immune responses. Stem Cells (2001) 1.08
Chondrogenic differentiation of mesenchymal stem cells and its clinical applications. Yonsei Med J (2004) 1.07
Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation processes in vitro. Arthritis Rheum (2009) 1.06
Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Osteoarthritis Cartilage (2010) 1.05
Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. Eur J Cell Biol (2008) 1.04
Progress and potential for regenerative medicine. Annu Rev Med (2007) 1.02
Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells. Exp Cell Res (2004) 1.01
Ultrastructural study of chondrocytes from fibrillated and non-fibrillated human osteoarthritic cartilage. Osteoarthritis Cartilage (1996) 0.98
Involvement of CC chemokines in gammadelta T lymphocyte trafficking during allergic inflammation: the role of CCL2/CCR2 pathway. Int Immunol (2007) 0.97
High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA. Stem Cell Res Ther (2013) 0.97
Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Med Hypotheses (2008) 0.95
Stem cells for cardiac repair: status, mechanisms, and new strategies. Stem Cells Int (2011) 0.95
Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors. Anticancer Res (2004) 0.94
Tissue engineering in the rheumatic diseases. Arthritis Res Ther (2009) 0.94
Preclinical and clinical data for the use of mesenchymal stem cells in articular cartilage tissue engineering. Expert Opin Biol Ther (2012) 0.93
Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Cell Tissue Res (2009) 0.92
Current clinical therapies for cartilage repair, their limitation and the role of stem cells. Curr Stem Cell Res Ther (2012) 0.92
Hypoxic regulation of mesenchymal stem cell migration: the role of RhoA and HIF-1α. Cell Biol Int (2011) 0.92
Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res (2009) 0.91
Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked PEG scaffolds with tunable stiffness. Biomaterials (2012) 0.91
Osteogenic differentiation influences stem cell migration out of scaffold-free microspheres. Tissue Eng Part A (2010) 0.90
Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues. Vet Immunol Immunopathol (2006) 0.90
Basic science and surgical treatment options for articular cartilage injuries of the knee. J Orthop Sports Phys Ther (2012) 0.90
Expression of mucosal chemokines TECK/CCL25 and MEC/CCL28 during fetal development of the ovine mucosal immune system. Immunology (2007) 0.88
In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transpl Int (2011) 0.88
Transdifferentiation of mesenchymal stem cells-derived adipogenic-differentiated cells into osteogenic- or chondrogenic-differentiated cells proceeds via dedifferentiation and have a correlation with cell cycle arresting and driving genes. Differentiation (2013) 0.88
Outgrowth of chondrocytes from human articular cartilage explants and expression of alpha-smooth muscle actin. Wound Repair Regen (2000) 0.87
Clinical applications of mesenchymal stem cells in the treatment of fracture non-union and bone defects. Curr Stem Cell Res Ther (2012) 0.85
Chemokine profile of human serum from whole blood: migratory effects of CXCL-10 and CXCL-11 on human mesenchymal stem cells. Connect Tissue Res (2010) 0.85
Using the iHOP information resource to mine the biomedical literature on genes, proteins, and chemical compounds. Curr Protoc Bioinformatics (2007) 0.84
Chondrogenic potentials of human synovium-derived cells sorted by specific surface markers. Osteoarthritis Cartilage (2012) 0.84
Regenerative medicine in rheumatic disease-progress in tissue engineering. Nat Rev Rheumatol (2012) 0.84
Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond. Cardiol Res Pract (2011) 0.83
Intracellular signaling required for CCL25-stimulated T cell adhesion mediated by the integrin alpha4beta1. J Leukoc Biol (2007) 0.82
Articular cartilage repair with magnetic mesenchymal stem cells. Am J Sports Med (2013) 0.82
Assessment of the profiling microRNA expression of differentiated and dedifferentiated human adult articular chondrocytes. J Orthop Res (2011) 0.82
Therapeutic potentials of stem cells in cardiac diseases. Minerva Cardioangiol (2009) 0.81
A reliable protocol for the isolation of viable, chondrogenically differentiated human mesenchymal stem cells from high-density pellet cultures. Biores Open Access (2012) 0.80
Future of tissue engineering in rheumatic diseases. Expert Opin Biol Ther (2007) 0.80
A new platelet cryoprecipitate glue promoting bone formation after ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude mice. Stem Cell Res Ther (2013) 0.79
Cytokine cues. Nat Rev Cancer (2011) 0.77
Allotransplanted neurons used to repair peripheral nerve injury do not elicit overt immunogenicity. PLoS One (2012) 0.77
Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials (2005) 2.60
Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems. Trends Biotechnol (2004) 1.93
Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem (2007) 1.86
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood (2007) 1.70
Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? Breast Cancer Res Treat (2010) 1.63
Mechanical testing of fixation techniques for scaffold-based tissue-engineered grafts. J Biomed Mater Res B Appl Biomater (2007) 1.61
Periosteal cells in bone tissue engineering. Tissue Eng (2003) 1.54
Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical results. Arthritis Res Ther (2007) 1.45
Primary tumor excision in stage IV breast cancer at diagnosis without influence on survival: a retrospective analysis and review of the literature. Onkologie (2011) 1.44
BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation (2003) 1.42
Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells (2009) 1.37
Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci U S A (2009) 1.35
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas. Haematologica (2012) 1.30
Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res Ther (2008) 1.28
The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties. Stem Cells Dev (2010) 1.25
Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res Ther (2009) 1.21
Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Eur J Haematol (2006) 1.21
Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. J Orthop Res (2009) 1.19
A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells. Biotechnol Prog (2007) 1.19
Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma. Clin Cancer Res (2003) 1.14
Regeneration of ovine articular cartilage defects by cell-free polymer-based implants. Biomaterials (2007) 1.12
Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. Anticancer Res (2012) 1.11
Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell Tissue Res (2002) 1.10
Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials (2012) 1.08
Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol (2008) 1.07
Stem cells for regenerative medicine: advances in the engineering of tissues and organs. Naturwissenschaften (2002) 1.04
Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. Eur J Cell Biol (2008) 1.04
Mesenchymal stem cell-dependent formation of heterotopic tendon-bone insertions (osteotendinous junctions). Stem Cells (2010) 1.03
Tissue engineering: advances in in vitro cartilage generation. Trends Biotechnol (2002) 1.03
Identification of clinically relevant yeasts by PCR/RFLP. J Microbiol Methods (2004) 1.02
BMP7 promotes adipogenic but not osteo-/chondrogenic differentiation of adult human bone marrow-derived stem cells in high-density micro-mass culture. J Cell Biochem (2007) 1.02
Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7. Int J Biochem Cell Biol (2008) 1.01
Regenerative treatment strategies in spinal surgery. Front Biosci (2008) 1.00
Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen (2007) 0.97
Making bone: implant insertion into tissue-engineered bone for maxillary sinus floor augmentation-a preliminary report. J Craniomaxillofac Surg (2003) 0.96
Chondrogenic differentiation capacity of human mesenchymal progenitor cells derived from subchondral cortico-spongious bone. J Orthop Res (2008) 0.96
Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol (2010) 0.96
Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica (2007) 0.94
Tissue engineering in the rheumatic diseases. Arthritis Res Ther (2009) 0.94
Differential gene expression profiling of human bone marrow-derived mesenchymal stem cells during adipogenic development. BMC Genomics (2011) 0.93
Distinct roles of BMP receptors Type IA and IB in osteo-/chondrogenic differentiation in mesenchymal progenitors (C3H10T1/2). Biofactors (2004) 0.93
Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer. Breast Cancer Res Treat (2013) 0.93
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions. PLoS One (2013) 0.93
Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Cell Tissue Res (2009) 0.92
Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis. PLoS One (2012) 0.92
Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources. Exp Cell Res (2010) 0.92
The morphology and biomechanical characteristics of subcutaneously implanted tissue-engineered human septal cartilage. Eur Arch Otorhinolaryngol (2005) 0.92
The arthroscopic implantation of autologous chondrocytes for the treatment of full-thickness cartilage defects of the knee joint. Arthroscopy (2003) 0.92
Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum (2002) 0.91
Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1. Cancer Lett (2012) 0.91
Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res (2009) 0.91
Rapid and simple differentiation of C. dubliniensis from C. albicans. Diagn Microbiol Infect Dis (2004) 0.91
Human bone marrow myeloma cells express RANKL. J Clin Oncol (2002) 0.91
Treatment of articular cartilage defects in horses with polymer-based cartilage tissue engineering grafts. Biomaterials (2006) 0.90
Gene expression profile of multipotent mesenchymal stromal cells: Identification of pathways common to TGFbeta3/BMP2-induced chondrogenesis. Cloning Stem Cells (2009) 0.90
Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: investigation for cartilage tissue engineering. Acta Biomater (2010) 0.90
Regeneration of intervertebral disc tissue by resorbable cell-free polyglycolic acid-based implants in a rabbit model of disc degeneration. Spine (Phila Pa 1976) (2008) 0.90
Synovial fluid recruits human mesenchymal progenitors from subchondral spongious bone marrow. J Orthop Res (2007) 0.89
Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma. Eur J Haematol (2002) 0.89
Immunocytochemistry reveals RANKL expression of myeloma cells. Blood (2002) 0.89
In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transpl Int (2011) 0.88
Transdifferentiation of mesenchymal stem cells-derived adipogenic-differentiated cells into osteogenic- or chondrogenic-differentiated cells proceeds via dedifferentiation and have a correlation with cell cycle arresting and driving genes. Differentiation (2013) 0.88
Breast Cancer-Associated Thrombotic Microangiopathy. Breast Care (Basel) (2011) 0.88
Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma. Leuk Lymphoma (2013) 0.87
Emulsion-based synthesis of PLGA-microspheres for the in vitro expansion of porcine chondrocytes. Biomol Eng (2007) 0.86
Osteogenic potential of human periosteum-derived progenitor cells in PLGA scaffold using allogeneic serum. J Zhejiang Univ Sci B (2006) 0.86
Gene expression profiling of human articular cartilage grafts generated by tissue engineering. Biomaterials (2006) 0.86
Chemokine profile of human serum from whole blood: migratory effects of CXCL-10 and CXCL-11 on human mesenchymal stem cells. Connect Tissue Res (2010) 0.85
Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III. J Cancer Res Clin Oncol (2003) 0.85
Tissue engineering of bone for mandibular augmentation in immunocompetent minipigs: preliminary study. Scand J Plast Reconstr Surg Hand Surg (2003) 0.85
Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis. Hum Mol Genet (2010) 0.85
Dual PPARalpha/gamma ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines. Cell Cycle (2006) 0.85
A tissue-engineering model for the manufacture of auricular-shaped cartilage implants. Eur Arch Otorhinolaryngol (2002) 0.84
Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis. PLoS One (2011) 0.84